Literature DB >> 2426315

Erythema chronicum migrans of Lyme disease: diagnosis by monoclonal antibodies.

H K Park, B E Jones, A G Barbour.   

Abstract

We demonstrated spirochetes from a skin lesion of the erythema chronicum migrans in a patient with Lyme disease by the murine monoclonal antibody (H9724). Frozen skin biopsy specimens reacted with murine monoclonal antibodies (H5332, H9724, and H4825) and were examined by indirect immunofluorescence assay. The spirochetes stained with monoclonal antibody H9724 and fluorescein isothiocyanate-conjugated second antibody (goat antimouse IgG). The antibody H9724 is specific for the periplasmic flagellae (axial filaments) of several Borrelia species, including Ixodes dammini spirochete (Borrelia burgdorferi). No immunofluorescence staining was demonstrated with either monoclonal antibody H5332, specific for an outer membrane protein of North American strains of B. burgdorferi, or the antibody H4825, specific for an outer membrane protein of B. hermsii.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426315     DOI: 10.1016/s0190-9622(86)70190-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  12 in total

1.  Laboratory confirmation of Lyme disease.

Authors:  T G Schwan; W J Simpson; P A Rosa
Journal:  Can J Infect Dis       Date:  1991

2.  Characterization of VspB of Borrelia turicatae, a major outer membrane protein expressed in blood and tissues of mice.

Authors:  P M Pennington; D Cadavid; A G Barbour
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene.

Authors:  R Wallich; S E Moter; M M Simon; K Ebnet; A Heiberger; M D Kramer
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Monoclonal antibodies for clinical applications. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1988-12       Impact factor: 2.926

Review 5.  Laboratory aspects of Lyme borreliosis.

Authors:  A G Barbour
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

6.  Dual role of MyD88 in rapid clearance of relapsing fever Borrelia spp.

Authors:  Devin D Bolz; Rhianna S Sundsbak; Ying Ma; Shizuo Akira; John H Weis; Tom G Schwan; Janis J Weis
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

7.  Diagnostic value of PCR for detection of Borrelia burgdorferi DNA in clinical specimens from patients with erythema migrans and Lyme neuroborreliosis.

Authors:  A M Lebech; K Hansen; F Brandrup; O Clemmensen; L Halkier-Sørensen
Journal:  Mol Diagn       Date:  2000-06

8.  Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; S Jauris; A Hofmann; I Pradel; E Soutschek; E Schwab; G Will; G Wanner
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Meningitis due to Borrelia burgdorferi in the initial stage of Lyme disease.

Authors:  H I Huppertz; V Sticht-Groh
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

10.  Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus.

Authors:  V Fingerle; U Hauser; G Liegl; B Petko; V Preac-Mursic; B Wilske
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.